Others commented that the program should target those individuals whose activities

and settings predispose them to contracting the virus but that payment for the vaccine should be the responsibility of these individuals. With the knowledge that although many individuals know the correct ZD1839 mw methods to prevent WNv exposure but a smaller percentage actually practice these prevention, the addition of a vaccine could substantially decrease the number of WNv symptomatic cases within the province of Saskatchewan. If the chimeric yellow fever–WNV vaccine were approved, most public health practitioners would consider it as generally safe and effective. However, many quite correctly questioned the safety of administering a live vaccine to immunosuppressed individuals. Therefore, if vaccination programs were designed to specifically target those at highest risk, information about the

safety of administration of the vaccine in these groups would need to be relayed to health care professionals. This study only sampled a portion of the health care sector and in the end should be inhibitors viewed as more of a key informant survey than a randomized survey design. While there was Epigenetic inhibitor a good response from medical health officers and public health nurses, the study was unable to enroll and question general practitioners. When it comes to new vaccine acceptability, it is only step one to assess the health care profession’s knowledge and acceptability. The next step will be to survey the general public to assess their attitudes Adenosine towards the use of a WNV vaccine as a preventive measure. “
“Current foot-and-mouth disease (FMD) vaccines consist of chemically inactivated whole virus antigen

that are formulated with either aluminium hydroxide/saponin or mineral oil adjuvant, depending on the target species [1]. Although these vaccines are capable of protecting animals from clinical disease they do not confer sterile immunity. The possibility of undisclosed infection in vaccinated animals necessitates methods to identify this and these rely on serological tests that can differentiate the immune response elicited by vaccination from that due to infection. Currently, this is achieved by purifying the vaccine antigen to remove FMD virus (FMDV) non-structural proteins (NSP) and then using detection of NSP antibodies as an indicator of infection [2]. However, vaccine preparations, depending on their source, can contain traces of NSP, reducing the specificity of the NSP assays [2]. Additionally, some vaccinated animals exposed to infection can become asymptomatic carriers, without an associated NSP seroconversion [3]. Therefore, there is a need for an additional and more reliable means of discriminating vaccinated and infected animals.